Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07394725Phase 1Completed

Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management

Role: lead

NCT06975488Not ApplicableCompleted

Effectiveness of LASER in Treatment of Ureteric Stones.

Role: lead

NCT06707051Phase 2Completed

Effect of Tranexamic Acid and Calcium Dobesilate for Bleeding of Endometrial Origin

Role: lead

NCT04958564Not ApplicableCompleted

Comparison of Interlock Nailing Versus Dynamic Compression Plating in Transverse Fractures of Tibia

Role: lead

All 4 trials loaded